Clinical Trials · NCT07850050
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 600
- Start date
- Oct 2026
- Locations
- 1 site, United States
- Primary endpoint
- Percentage change in body weight from baseline to Week 52